These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 38555700)

  • 21. Advanced neuroimaging in neuropsychiatric systemic lupus erythematosus.
    Mackay M; Tang CC; Vo A
    Curr Opin Neurol; 2020 Jun; 33(3):353-361. PubMed ID: 32349105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse models, antibodies, and neuroimaging: Current knowledge and future perspectives in neuropsychiatric systemic lupus erythematosus (NPSLE).
    Tomalla V; Schmeisser MJ; Weinmann-Menke J
    Front Psychiatry; 2023; 14():1078607. PubMed ID: 36970286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychiatric Systemic Lupus Erythematosus in Older Adults: Diagnosis and Management.
    Tayer-Shifman OE; Bingham KS; Touma Z
    Drugs Aging; 2022 Feb; 39(2):129-142. PubMed ID: 34913146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
    Bleeker G; Tytgat GA; Adam JA; Caron HN; Kremer LC; Hooft L; van Dalen EC
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009263. PubMed ID: 26417712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma.
    Vaarwerk B; Breunis WB; Haveman LM; de Keizer B; Jehanno N; Borgwardt L; van Rijn RR; van den Berg H; Cohen JF; van Dalen EC; Merks JH
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012325. PubMed ID: 34753195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into the role of neutrophils in neuropsychiatric systemic lupus erythematosus: Current understanding and future directions.
    Sim TM; Mak A; Tay SH
    Front Immunol; 2022; 13():957303. PubMed ID: 36016935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Smailagic N; Vacante M; Hyde C; Martin S; Ukoumunne O; Sachpekidis C
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010632. PubMed ID: 25629415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
    Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
    Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET/CT imaging in systemic lupus erythematosus.
    Curiel R; Akin EA; Beaulieu G; DePalma L; Hashefi M
    Ann N Y Acad Sci; 2011 Jun; 1228():71-80. PubMed ID: 21718325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Future Perspectives in the Diagnosis of Neuropsychiatric Lupus by Advanced Magnetic Resonance Imaging Techniques.
    Sarbu N; Sarbu MI; Bargallo N; Cervera R
    Curr Rheumatol Rev; 2018; 14(3):213-218. PubMed ID: 29637864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE).
    Hermosillo-Romo D; Brey RL
    Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):229-44. PubMed ID: 12041951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and Management of Pediatric Neuropsychiatric Systemic Lupus Erythematosus: An Update.
    Unal D; Cam V; Emreol HE; Özen S
    Paediatr Drugs; 2024 Jul; 26(4):381-395. PubMed ID: 38805115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology, characterization, and diagnosis of neuropsychiatric events in systemic lupus erythematosus.
    de Amorim JC; Frittoli RB; Pereira D; Postal M; Dertkigil SSJ; Reis F; Costallat LT; Appenzeller S
    Expert Rev Clin Immunol; 2019 Apr; 15(4):407-416. PubMed ID: 30632405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging in CNS lupus.
    Peterson PL; Axford JS; Isenberg D
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):727-39. PubMed ID: 16150400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in the diagnosis, pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus.
    Moore E; Huang MW; Putterman C
    Curr Opin Rheumatol; 2020 Mar; 32(2):152-158. PubMed ID: 31895125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus.
    Duarte-Delgado NP; Vásquez G; Ortiz-Reyes BL
    Autoimmun Rev; 2019 Apr; 18(4):426-432. PubMed ID: 30763633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
    Dammacco F; Rubini G; Ferrari C; Vacca A; Racanelli V
    Clin Exp Med; 2015 Feb; 15(1):1-18. PubMed ID: 25218739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of
    McDonald EO; Amanullah AA; Park PSU; Song W; Werner TJ; Alavi A; Revheim ME
    Ann Nucl Med; 2023 Jun; 37(6):328-348. PubMed ID: 37095393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of
    Ten Hove D; Treglia G; Slart RHJA; Damman K; Wouthuyzen-Bakker M; Postma DF; Gheysens O; Borra RJH; Mecozzi G; van Geel PP; Sinha B; Glaudemans AWJM
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):241-253. PubMed ID: 32594196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of Myocarditis: Cardiac MR, PET/CT, or PET/MR?
    Chen W; Jeudy J
    Curr Cardiol Rep; 2019 Jun; 21(8):76. PubMed ID: 31243587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.